{{Rsnum
|rsid=2075847
|Gene=MMP1
|Chromosome=11
|position=102799093
|Orientation=minus
|GMAF=0.1249
|Gene_s=COX6CP3,MMP1
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 0.0 | 0.9 | 99.1
| HCB | 3.6 | 35.0 | 61.3
| JPT | 3.5 | 30.1 | 66.4
| YRI | 8.8 | 40.1 | 51.0
| ASW | 12.3 | 33.3 | 54.4
| CHB | 3.6 | 35.0 | 61.3
| CHD | 11.9 | 31.2 | 56.9
| GIH | 3.0 | 26.7 | 70.3
| LWK | 8.2 | 36.4 | 55.5
| MEX | 0.0 | 10.3 | 89.7
| MKK | 4.5 | 28.2 | 67.3
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{omim
|desc=MATRIX METALLOPROTEINASE 1; MMP1
|id=120353
|rsnum=2075847
}}

{{omim
|id=610504
|rsnum=2075847
}}

{{PMID Auto
|PMID=19318431
|Title=No association between matrix metalloproteinase-1 or matrix metalloproteinase-3 polymorphisms and breast cancer susceptibility: a report from the Shanghai Breast Cancer Study.
|OA=1
}}

{{PMID Auto
|PMID=19435861
|Title=No association between matrix metalloproteinase (MMP)-1, MMP-3, and MMP-7 SNPs and endometrial cancer risk.
|OA=1
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}